GlassScriptPhysician profile
Hillary L Behn
NPI 1952812679
$3,268.97
in general payments reported to CMS, 2019-2025
23 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $252 · 2022: $578 · 2023: $656 · 2024: $687 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,919 · Travel and Lodging: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.45 |
| Travel and Lodging | $519.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $710.77 | 2022-2025 | Corevalve Evolut R, Micra, Cobalt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $464.78 | 2021-2025 | |
| Pfizer INC. | $357.62 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $269.40 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $184.44 | 2023-2025 | Farxiga, Brilinta, Andexxa |
| Bayer Healthcare Pharmaceuticals INC. | $168.90 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.82 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $134.68 | 2022-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $116.13 | 2021-2022 | |
| Amgen INC. | $108.09 | 2021-2024 | Repatha |
| Abbott Laboratories | $102.78 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx, Optis |
| Angiodynamics, INC. | $93.76 | 2022 | |
| Bridgebio Pharma, INC. | $71.29 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $52.77 | 2024-2025 | Evkeeza, Praluent |
| Teleflex LLC | $48.43 | 2022-2024 | Vascband, Turnpike |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.34 | 2023-2025 | Lifevest |
| Esperion Therapeutics, INC. | $44.33 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $36.82 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $22.50 | 2023 | Inpefa |
| Terumo Medical Corporation | $20.27 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $19.36 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $16.79 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $12.90 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Behn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.